Frame
Safer Proton Therapy for Cancer Treatment.
Right Treatment. Every Patient. Every Time.
Frame
Join Our Team
Take Proton Therapy to the next level.
Frame
Safer Proton Therapy for Cancer Treatment
Right treatment. Every patient. Every time.

News

Christina, our CEO, invited to “Meeting Women Executives in Tech” event organized by Science2Market at Pulse Incubateur HES

Christina, our CEO, invited to “Meeting Women Executives in Tech” event organized by Science2Market at Pulse Incubateur HES

Excited to celebrate and empower women in tech in Geneva. Join us for an exciting discussion on the road to innovation and entrepreneurship. https://www.science2market.ch/event-details/yes-you-can-meet-women-executives-in-tech Organized at Pulse Incubateur HES with the support of Innosuisse – Swiss Innovation Agency.
Christina, our CEO, invited to "Moving out of Academia to MedTech" as one of the panelists at this CERN alumni event

Christina, our CEO, invited to "Moving out of Academia to MedTech" as one of the panelists at this CERN alumni event

After 12 years at CERN, Christina co-founded Terapet SA, a Geneva-based MedTech company in 2019. Meet our CEO Christina at "Moving out of academia to Medtech" and she will share her journey with you.
Terapet wins Venture Kick Stage III, total CHF 150'000

Terapet wins Venture Kick Stage III, total CHF 150'000

Terapet’s real-time tracking of proton therapy dosage-delivery for cancer patients wins CHF 150,000
Today, Terapet is proud to announce the successful closing of the seed investment round of CHF 1 Million.

Today, Terapet is proud to announce the successful closing of the seed investment round of CHF 1 Million.

Today, Terapet is proud to announce the successful closing of the oversubscribed seed investment round of CHF 1 Million. This funding supports the development of our first full-scale prototype to be installed for clinical validation. This round was contributed by our new investors: EFI (Efficient Frontier Investing), Nina Capital, FSI…
Terapet: one of 10 Venture Finalists within Health & Nutrition vertical of this year's venture competition

Terapet: one of 10 Venture Finalists within Health & Nutrition vertical of this year's venture competition

Out of 327 submissions, the experts of Venture.ch chose 10 most promising startups in each of the verticals. It is our pleasure to be one of the top 10 Health & Nutrition finalists of this year’s Venture competition.
Terapet: one of Venture Leaders Life Science 2020. Representing Switzerland in the world capital of life sciences.

Terapet: one of Venture Leaders Life Science 2020. Representing Switzerland in the world capital of life sciences.

10 outstanding startups have been selected for this year’s Venture Leaders Life Sciences program. The winners will be celebrated at the Swiss Biotech Day in September and then travel to Boston, United States, for a week-long roadshow with the Swiss National Startup Team in November. Learn more!
Terapet: selected by Bilan as Top 50 Swiss Startups in which to invest in 2020

Terapet: selected by Bilan as Top 50 Swiss Startups in which to invest in 2020

Terapet: selected by Bilan as Top 50 Swiss Startups in which to invest in 2020.
Terapet SA accepted to the EIT Health Investor Network

Terapet SA accepted to the EIT Health Investor Network

We are happy to announce that Terapet SA has gone through the EIT selection process and we have met the requirements to enter the EIT Health Investor Network. EIT (European Institute of Innovation and Technology) is an EU body created by the European Union in 2008 to strengthen Europe’s ability…
Terapet SA: a member of Swiss MedTech

Terapet SA: a member of Swiss MedTech

Today Terapet became a member in the Swiss MedTech community.   Swiss Medtech was established on 12 June 2017 following the merger of two national medtech organizations, FASMED and Medical Cluster. The new association represents the interests of the Swiss medtech industry. The aim is to maintain international competitiveness, innovative…
Today Terapet SA is featured as one of the Top10 Swiss MedTech rising stars by Venturelab

Today Terapet SA is featured as one of the Top10 Swiss MedTech rising stars by Venturelab

10 Swiss Medtech Startups to Watch in 2020 Thanks to Venturelab to select Terapet SA as one of Top10 Swiss MedTech Startups to Watch in 2020. Read more: Venturelab link.  
Terapet SA selected as one of the six high-tech startups in the Israel-Swiss Lean Launchpad program

Terapet SA selected as one of the six high-tech startups in the Israel-Swiss Lean Launchpad program

Once again we thank Innosuisse – Agence suisse pour l’encouragement de l’innovation for their constant trust and support. Terapet is among the 6 high-tech startups which have been selected by Innosuisse for the Israel-Swiss Lean Launchpad program. This exchange program will give the companies the opportunity to attend workshops while…
TERAPET passed Venture Kick Stage 2 and won CHF 40’000

TERAPET passed Venture Kick Stage 2 and won CHF 40’000

Today, TERAPET passed Venture Kick Stage 2 and won CHF 40'000.
Find Terapet as one of the presenting companies at 7th edition of Innovation for Health in February in Rotterdam

Find Terapet as one of the presenting companies at 7th edition of Innovation for Health in February in Rotterdam

Come and find us as one of the presenting startups at 7th edition of Innovation for Health on 12-13 February in Rotterdam.
TERAPET SA incorporated and we officially joined Fongit

TERAPET SA incorporated and we officially joined Fongit

Since 27.11.2019, Terapet SA was incorporated and officially joined Fongit, Geneva. Terapet SA successfully closed a pre-seed round and welcomed two new board of directors (Didier Cowling and Antonio Gambardella) to join our company.
TERAPET among Top10 at Swiss Innovation Challenge 2019

TERAPET among Top10 at Swiss Innovation Challenge 2019

Terapet has successfully reached Top10 of this year's Swiss Innovation Challenge and was one of 29 finalists over 140 initial participants.
Terapet is featured on the front page of l'agefi today

Terapet is featured on the front page of l'agefi today

Terapet is featured on the front page of l’agefi on Monday’s edition. Thank you so much to the great team!
CHF 100,000 to make proton therapy more effective

CHF 100,000 to make proton therapy more effective

Terapet, a startup based near Nyon, has just been awarded a CHF 100,000 Tech Seed loan from Vaud’s Foundation for Technological Innovation (FIT). Read press release from Startupticker.ch.
TERAPET passed Venture Kick Stage 1 and won CHF 10'000

TERAPET passed Venture Kick Stage 1 and won CHF 10'000

Yesterday, TERAPET passed Venture Kick Stage 1 and won CHF 10'000.
TERAPET attending ISOP2019 (International Symposium on Proton Therapy), Madrid

TERAPET attending ISOP2019 (International Symposium on Proton Therapy), Madrid

This year, ISOP3 was held in Madrid, co-organized by QuirónSalud and IBA. Our co-founder, Prof. Raymond Miralbell, Medical Director at the first center for proton therapy in Spain, that is expected to be operational by the end of this year, was one of the main organizers for this event and…
TERAPET wins Swiss BIC of CERN Technologies and receives a cash grant of CHF 50,000

TERAPET wins Swiss BIC of CERN Technologies and receives a cash grant of CHF 50,000

TERAPET wins the 2019 Swiss BIC of CERN Technologies at PARK INNOVAARE next to PSI, Villigen in Switzerland and receives a cash grant of CHF 50,000.
Startupticker.ch: BIC of CERN selects Arc Power and Terapet as new incubatees

Startupticker.ch: BIC of CERN selects Arc Power and Terapet as new incubatees

Swiss BIC of CERN Technologies offers a two-year entrepreneurship program to support high tech startups in implementing their ideas. During the incubation, participants benefit from a wide range of offers including access to accelerator technology expertise. Each of the companies receives a cash grant of 50’000CHF. Read the press release…
Meet our CTO, Marcus Palm at Geneus

Meet our CTO, Marcus Palm at Geneus

Marcus Palm, our CTO, interviewed by the Geneus team.
TERAPET CEO Panel speaker at EPFL

TERAPET CEO Panel speaker at EPFL

Christina Vallgren invited as panel speaker at EPFL
Elevator Pitch by our CTO, Marcus Palm at Swiss Innovation Challenge 2019

Elevator Pitch by our CTO, Marcus Palm at Swiss Innovation Challenge 2019

Meet TERAPET's CTO, Marcus Palm at Swiss Innovation Challenge 2019.
TERAPET one of the finalists of Masschallenge Switzerland 2019

TERAPET one of the finalists of Masschallenge Switzerland 2019

TERAPET entered the final of Masschallenge Switzerland 2019.
TERAPET CEO: Top Swiss Female Entrepeneur

TERAPET CEO: Top Swiss Female Entrepeneur

Thanks to Venturelab for the nomination as one of the top Swiss female Entrepreneurs, 8/3/2019! Since 2004, Venturelab designs and operates flagship programs such as Innosuisse Start-up Trainings, Venture Kick, Venture Leaders, TOP 100 Swiss Startup Award to support the best entrepreneurial talents. Together with successful founders, leading academic and…